Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Cash Flow Reinvestment Rate
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Cash Flow Reinvestment Rate of 0.18x as of September 2024, reinvesting TL5.93 Million (capex TL2.91 Million plus investments TL-3.03 Million) from operating cash flow of TL33.37 Million. See ONCSM FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 3 annual periods. For the full cash flow conversion analysis, see Oncosem Onkolojik Sistemler Sanayi ve Ti cash flow conversion.
Annual Cash Flow Reinvestment Rate for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2022)
Year-by-year capital reinvestment analysis for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. See ONCSM financial flexibility index to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.01x | TL53.09 Million | TL52.69 Million | TL26.02 Million | ▲ +38.0% |
| 2021 | 0.73x | TL37.73 Million | TL51.68 Million | TL0.00 | ▼ -12.7% |
| 2020 | 0.84x | TL16.23 Million | TL19.41 Million | TL0.00 | — |